Stephanthraniline A suppresses proliferation of HCT116 human colon cancer cells through induction of caspase-dependent apoptosis, dysregulation of mitochondrial function, cell cycle arrest and regulation of Akt/p38 signaling pathways

The Journal of Toxicological Sciences
Lu WangYi-Qi Wang

Abstract

Stephanthraniline A (STA) is a C21 steroidal aglycone isolated from the stem of Stephanotis mucronata (Blanco) Merr. that exerts growth inhibition in human colon cancer cells. However, the intracellular molecular mechanisms whereby this occurs have not been well characterized. In this study, we found that STA significantly inhibits the growth of HCT116 colon cancer cells in a time- and concentration-dependent manner. The inhibitory effect of STA on cell growth was related to the induction of apoptosis. Activated caspase-3, caspase-8 and caspase-9, along with a decreased Bcl-2/Bcl-x ratio and loss of mitochondrial membrane potential (Δψm), were observed in response to STA treatment. Furthermore, treatment of HCT116 cells with STA resulted in G0/G1 phase cell cycle arrest accompanied by decreased mRNA levels of cyclin-dependent kinase 4 (CDK4), p21 and c-myc. Additionally, the inhibition of Akt signaling and activation of p38 signaling were observed after treatment with STA in HCT116 cells. These findings indicate that STA inhibits HCT116 cell growth by promoting apoptosis, the dysregulation of mitochondrial function, and cell cycle arrest.

References

May 7, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M Fan, T C Chambers
Nov 25, 2003·Oncogene·Alexei DegterevJunying Yuan
Oct 13, 2006·Annual Review of Pharmacology and Toxicology·Sten OrreniusBoris Zhivotovsky
Oct 29, 2008·Oncogene·T F Franke
Feb 25, 2009·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
May 15, 2009·Nature Reviews. Cancer·Tarek Abbas, Anindya Dutta
Mar 31, 2010·Anti-cancer Drugs·Kaiyang LiuHongQuan Zhang
May 1, 2012·European Journal of Pharmacology·Fengyang ChenShifang Xu
Jan 31, 2015·Nature Reviews. Drug Discovery·Uzma AsgharErik S Knudsen
May 11, 2015·Apoptosis : an International Journal on Programmed Cell Death·Meenakshi TiwariShail K Chaube
Jun 25, 2016·Seminars in Nephrology·Steven C Borkan
Apr 5, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Ren-Hong HuangZhi-Jun Min
Nov 17, 2017·Genes & Development·Ottavio CrociStefano Campaner
Dec 7, 2018·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis